PE/VC investors
Private Equity (PE) and Venture Capital (VC) investors are the catalysts of innovation and growth in the business world. PE firms primarily target established companies, seeking to optimize operations and unlock value through strategic investments and management expertise. They focus on long-term growth and profitability, often preparing businesses for a future sale or IPO. VC investors, by contrast, are the adventurers of finance, injecting capital into high-potential startups and early-stage companies. They embrace risk for the possibility of outsized returns, often becoming invaluable advisors. Both investor types not only bring capital but also strategic guidance, industry connections, and market insights, propelling their portfolio companies towards success.
Investors (6,251)
Investor
Description
More information
John Laing Group Plc
John Laing is an international originator, active investor and manager of infrastructure projects. Its business is focused on major transport, social and environmental infrastructure projects awarded under governmental public-private partnership (PPP) programmes, and renewable energy projects, across a range of international markets including the UK, Europe, Asia Pacific and North America.
Johnson & Johnson
![Johnson & Johnson]()
At Johnson & Johnson, we believe good health is the foundation of vibrant lives, thriving communities and forward progress. That’s why for more than 130 years, we have aimed to keep people well at every age and every stage of life. Today, as the world’s largest and most broadly based healthcare company, we are committed to using our reach and size for good. We strive to improve access and affordability, create healthier communities, and put a healthy mind, body and environment within reach of everyone, everywhere.
Every day, our more than 130,000 employees across the world are blending heart, science and ingenuity to profoundly change the trajectory of health for humanity.
At Johnson & Johnson, we blend heart, science and ingenuity to profoundly change the trajectory of health for humanity. We aspire to positively impact patients, consumers and all others we serve with our life-saving medicines, products and devices, as well as the health of our employees, our communities and the planet. We seek to provide solutions for some of the world’s most pressing global public health challenges and work collectively—within our walls and externally with partners—to advance better health for all.
Enterprise, Social and Governance (ESG) Investors Update Webcast
At Johnson & Johnson, our sustainability approach means generating social, environmental and economic value for all of Our Credo stakeholders: patients, consumers, healthcare providers and all others we serve, employees, the communities in which we live and work, business partners, investors and society as a whole.
Our Health for Humanity 2025 Goals focus our citizenship and sustainability efforts where we believe Johnson & Johnson can achieve the greatest impact.
Johnson & Johnson
![Johnson & Johnson]()
Johnson & Johnson Innovation – JJDC, Inc. (JJDC) is the strategic venture capital arm of Johnson & Johnson. JJDC pursues opportunities to solve critical healthcare needs. Our portfolio companies benefit from the full global capabilities of Johnson & Johnson as we collaborate to drive innovation.
JJDC finds transformative ideas and helps them mature into real solutions for today’s patients.
Guided by a clear, consistent investment strategy aligned with scientific goals, JJDC works hand-in-hand with partners to navigate the path to creating breakthrough health innovations.
We invest across sectors—pharmaceuticals, medical devices and consumer healthcare—and at all stages, from seed-level startups to Series B and beyond.
All of our portfolio companies receive the same unwavering commitment. We take a long-term approach, deploying the full capabilities of the Johnson & Johnson family of companies, including discovery, clinical development, regulatory affairs, manufacturing and commercialization.
Our team includes leaders in the healthcare and technology communities, many with deep R&D experience. This gives us the ability to understand our partners and provide the help they need.
Every opportunity is unique, with tailored roles and terms that provide the best path to success.
Johnson and Johnson Innovation
Johnson & Johnson is the largest and most broadly based healthcare company in the world. We’re producing life-changing breakthroughs every day, and have been for the last 130 years. The combination of new technologies and your expertise enables amazing things to happen. Teams from J&J’s consumer business are creating digital tools to help people track the health of their skin. Those working in medical devices are 3-D printing artificial joints personalized for each patient, while researchers in pharmaceuticals use AI to discover lifesaving drugs. Imagine what the rest of our team of 134,000 people at 260 companies in more than 60 countries across the world is accomplishing. We redefine what it means to be a big company in today’s world.
Johnson Capital
Celebrating its 27th anniversary as a leading commercial real estate capital advisory firm, Johnson Capital provides a variety of real estate financing services including debt placement and acquisition financing for permanent loans, construction financing and property repositioning. In addition, it arranges joint venture equity placement for individual assets, portfolios, entities and discretionary funds. The firm is a leading national commercial real estate capital intermediary with direct lender relationships through Fannie Mae, Freddie Mac, HUD and many insurance companies.
<br />
Jolt Capital SAS
Jolt Capital SAS is a fully independent Private Equity firm authorized and regulated by AMF (Autorité des Marchés Financiers) that specialises in Technology, targeting investments into companies with revenues between $10m and $100m.
Jonkoping Business Development AB
JBD invests in companies with growth potential. We want to help companies grow and become profitable, through both capital and active ownership. We are mainly owned by a number of private investors and other owners are Jönköping University and Science Park Jönköping. We have our base in the Jönköping region but also invest in nearby areas.
Joy Capital
JOY CAPITAL invests in startups of both early and growth stages and focuses on TMT and innovative consumption sectors. “Do Hard Things with JOY”. JOY CAPITAL keeps partnering with entrepreneurs for helping them make right decisions at key moments during a startup’s developments and sharing the hardship and joy with them while starting their business. Founding partners of JOY CAPITAL have invested in more than 80 startups and over 10 portfolios they’ve invested in are unicorns.
Joyance Partners
Joyance Partners is a venture capital partnership that invests in companies with the capacity to deliver, or contribute to the delivery of, Delightful Moments.<br />
<br />
Delightful Moments are part of all human experience. They are the small, but powerful, separations from the daily humdrum. They are the moments when we feel a bit stronger, calmer, more joyful, more in control, and more in tune with the greater universe. Now, a range of new technologies has the potential to deliver these experiences. Science can help individuals be a bit happier, which can lead to greater health. Or a little healthier, which can lead to greater potential for happiness. It is a new, transformative cycle of human experience.
Jozi Angels
Jozi Angels is an angel network based in Johannesburg, South Africa. We exist to grow the startup ecosystem and facilitate the growth of innovative startups. Through our broader network we have sourced the hottest startups and facilitated several investments. Our members are approved investors serious about providing capital and coaching to early stage companies.
